Registered Office:
129/1/A GIDC Estate Nandesari,,
Vadodara -
391340,
Gujarat, India.
Phone : +91 265 284 0656/329 1354 Fax:
Email : cs.sudeep@sudeepgroup.com
Website : https://www.sudeeppharma.com
|
| Initial public offer of 15,092,749 equity shares of face value of Re.1/- each ("equity shares") of Sudeep Pharma Limited ("company") for cash at a price of (Rs)593/- per equity share (including a share premium of (Rs)592/- per equity share) ("offer price") aggregating to (Rs)895.00 crores comprising a fresh issue of 1,602,023 equity shares of face value of Re.1/- aggregating to (Rs) 95.00 crores by the company ("fresh issue") and an offer for sale of 13,490,726 equity shares of face value of Re.1/- aggregating to (Rs)800.00 crores ("offered shares") by the selling shareholders, consisting of 3,567,670 equity shares of face value of Re.1/- aggregating to (Rs)211.56 crores by SujitJjaysukh Bhayani, 8,418,856 equity shares of face value of Re.1/- aggregating to (Rs) 499.24 crores by Sujeet Jaysukh Bhayani HUF, 750,000 equity shares of face value of Re.1/- aggregating to (Rs)44.48 crores by Shanil Sujit Bhayani and 754,200 equity shares of face value of Re.1/- aggregating to (Rs)44.72 crores by Avani Sujit Bhayani (collectively "the selling shareholders") and such equity shares offered by the selling shareholders ("offer for sale", and together with the fresh issue, the "offer"). |
|
| Issue |
Money Payable On |
| Opens On |
Closes On |
Application |
Allotment |
| 21-Nov-25 |
25-Nov-25 |
593.00-0.00 |
0.00-0.00 |
|
|
Minimum Application for shares in Nos :
25
Further Multiples of :
25
|
|
| |
(Rs.Cr) |
Lead Managers to the Issue |
| Project Cost |
88.48 |
ICICI Securities Limited
|
| Project Financed through Current Offer |
895.00 |
|
| Post Issue Equity Share Capital |
11.29 |
|
| Issue Price |
593.00 |
|
|